Publications 2026

Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M (2026)
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study
BMJ Neurol Open, 8 (1), e001556
DOI 10.1136/bmjno-2026-001556, PubMed 41835014

Publications 2022

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
JAMA Neurol, 79 (3), 307-309
DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702

Publications 2021

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
J Neurol Neurosurg Psychiatry, 94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Publications 2018

Tran TT, Bollineni RC, Koehler CJ, Thiede B (2018)
Absolute two-point quantification of proteins using dimethylated proteotypic peptides
Analyst, 143 (18), 4359-4365
DOI 10.1039/c8an01081a, PubMed 30112540

Publications 2017

Tran TT, Strozynski M, Thiede B (2017)
Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells
Proteomics, 17 (11)
DOI 10.1002/pmic.201600470, PubMed 28464451